Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › RNAi inhibition of CTGF for treatment of ocular disorders

RNAi inhibition of CTGF for treatment of ocular disorders

US Patent 7622454 · Granted Nov 24, 2009

Estimated economic value: $201,536,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of treating ophthalmic diseases using NPR-B agonists2017
Methods of treating ophthalmic diseases using NPR-B agonists2015
NPR-B agonists2013
Bradykinin receptor agonists and uses thereof to treat ocular hypertension and g2012
RNAi inhibition of CTGF for treatment of ocular disorders2010
RNAi inhibition of CTGF for treatment of ocular disorders2010
Use of inhibitors of Jun N-terminal kinases to treat glaucoma2010
Method of treating glaucoma2009
Inhibitors of glycogen synthase kinase-3 (GSK-3) for treating glaucoma2009
RNAi-mediated inhibition of ocular targets2009
Use of non-feminizing estrogens as treatment for retinal vascular diseases2009
Use of non-feminizing estrogens as retinoprotective agents for the treatment of 2008